Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
USANA Health Sciences, Inc. (USNA) had Consolidated Net Income/Loss of $-1.59M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$226.20M |
|
$-1.77M |
|
$49.41M |
|
$176.79M |
|
$222.38M |
|
$3.82M |
|
$0.36M |
|
$4.18M |
|
$4.18M |
|
$-1.59M |
|
$-1.59M |
|
|
Consolidated Net Income/Loss |
$-1.59M |
$-1.59M |
|
$3.82M |
|
$14.11M |
|
18.54M |
|
18.57M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$288.40M |
|
$94.38M |
|
$454.51M |
|
$742.91M |
|
$128.56M |
|
-- |
|
$81.25M |
|
$209.81M |
|
$533.10M |
|
$261.99M |
|
$533.10M |
|
18.28M |
|
| Cash Flow Statement Financials | |
$22.35M |
|
$-10.12M |
|
$-40.60M |
|
$184.51M |
|
$161.24M |
|
$-23.27M |
|
$13.83M |
|
$-1.75M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
78.16% |
|
1.69% |
|
1.69% |
|
-- |
|
1.85% |
|
-0.78% |
|
$12.43M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.48 |
|
-- |
|
-- |
|
-0.30% |
|
-0.61% |
|
-0.21% |
|
-0.30% |
|
$29.16 |
|
$0.67 |
|
$1.20 |
|